DCGO Stock Recent News

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that its Ambulnz subsidiary was awarded a multi-year $3.4 million contract to provide medical transportation services to the Albany Stratton VA Medical Center. Under the contract, Ambulnz by DocGo will provide basic life support, advanced life support and critical care ambulance services for patients needing.

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that the Company will participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24 and 25, 2025. Representing the Company, CEO Lee Bienstock will deliver a presentation at 1:00 ET on Tuesday, June 24, followed by one-on-one meetings with investors on Wednesday, June 25. A w.

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that Lee Bienstock, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9th from 4:00 – 4:35 PM Eastern Time, and hold 1x1 meetings as well. A webcast of the event will be available on the investor relations section of DocGo's website at ht.

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DocGo, Inc. (NASDAQ: DCGO) breached their fiduciary duties to shareholders.

NEW YORK , May 29, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DocGo, Inc. (NASDAQ: DCGO)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, DocGo insiders caused the company to misrepresent or fail to disclose that (i) the processes DocGo used to hire executives were insufficient for thoroughly examining and verifying the professional and educational backgrounds of applicants; (ii) this inadequacy heightened the risk of disruptive changes in executive leadership; (iii) contrary to what it had communicated to investors, DocGo had overestimated the effectiveness of its mobile health and medical transportation services, which were key components of the Relocation Contract; (iv) all these issues, once disclosed, were likely to expose DocGo to considerable reputational and/or regulatory examination, adversely affecting the company's financial health and futur

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that it has been selected as winner of the “Compliance Management Innovation Award” in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market. DocGo's brea.

DocGo, Inc (NASDAQ:DCGO ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Mike Cole - VP, IR Lee Bienstock - CEO Norman Rosenberg - CFO Conference Call Participants Ryan MacDonald - Needham Kieran Ryan - Deutsche Bank Jenny Shen - BTIG Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo First Quarter Earnings Conference Call. At this time, all lines are in listen-only mode.

DocGo Inc. (DCGO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.09 per share a year ago.

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended March 31, 2025. Lee Bienstock, Chief Executive Officer of DocGo, commented, “The impact of ongoing policy changes in Washington and adjustments to public spending on healthcare-related projects have created substantial uncertainty in our Government Populat.

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into DocGo Inc. (NasdaqCM: DCGO). DocGo is a healthcare company that provides medical transportation and mobile health services in the United States and the United Kingdom. In September 2023, news media sources reported numerous alleged misrepresentations by the Company, includin.